Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
ETFs with AGN as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|5.28%||iShares U.S. Pharmaceutical ETF (IHE)||+25.93 (24.55%)|
|4.68%||Merrill Lynch Pharmaceutical HOLDRS (PPH)||+11.53 (24.09%)|
|4.19%||iShares MSCI Netherlands Index Fund (EWN)||+2.14 (8.96%)|
|3.97%||SPDR S&P Pharmaceuticals ETF (XPH)||+21.74 (27.99%)|
|3.06%||Columbia Select Large Cap Growth ETF (RWG)||+8.34 (21.82%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
We are a multi-specialty health care company focused on developing and commercializing innovative pharmaceuticals, biologics, medical devices and over-the-counter products that enable people to live life to its full potential - to see more clearly, move more freely and express themselves more fully. We discover, develop and commercialize a diverse range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets in more than 100 countries around the world. We are also a pioneer in specialty pharmaceutical, biologic and medical device research and development. Our research and development efforts are focused on products and technologies related to the many specialty areas in which we currently operate as well as new specialty areas where unmet medical needs are significant. In 2013, our research and development expenditures were approximately 16. ... More ...
|Annual EPS Est:||$4.77|
|Quarterly EPS Est:||1.11|